• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构基础的中和与保护的寨卡病毒特异性的人类抗体。

Structural Basis for Neutralization and Protection by a Zika Virus-Specific Human Antibody.

机构信息

Beijing Advanced Innovation Center for Structural Biology, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Center for Global Health and Infectious Diseases, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China.

Comprehensive AIDS Research Center, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing Advanced Innovation Center for Structural Biology, Center for Global Health and Infectious Diseases, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China.

出版信息

Cell Rep. 2019 Mar 19;26(12):3360-3368.e5. doi: 10.1016/j.celrep.2019.02.062.

DOI:10.1016/j.celrep.2019.02.062
PMID:30893607
Abstract

We previously reported a human monoclonal antibody, ZK2B10, capable of protection against Zika virus (ZIKV) infection and microcephaly in developing mouse embryos. Here, we report the structural features and mechanism of action of ZK2B10. The crystal structure at a resolution of 2.32 Å revealed that the epitope is located on the lateral ridge of DIII of the envelope glycoprotein. Cryo-EM structure with mature ZIKV showed that the antibody binds to DIIIs around the icosahedral 2-fold, 3-fold, and 5-fold axes, a distinct feature compared to those reported for DIII-specific antibodies. The binding of ZK2B10 to ZIKV has no detectable effect on viral attachment to target cells or on conformational changes of the E glycoprotein in the acidic environment, suggesting that ZK2B10 functions at steps between the formation of the fusion intermediate and membrane fusion. These results provide structural and mechanistic insights into how ZK2B10 mediates protection against ZIKV infection.

摘要

我们之前报道了一种人源单克隆抗体 ZK2B10,它能够预防寨卡病毒(ZIKV)感染和发育中的小鼠胚胎小头畸形。在这里,我们报告了 ZK2B10 的结构特征和作用机制。分辨率为 2.32 Å 的晶体结构显示,表位位于包膜糖蛋白 DIII 的侧脊上。带有成熟 ZIKV 的冷冻电镜结构显示,该抗体结合在二十面体 2 重轴、3 重轴和 5 重轴周围的 DIII,这与报道的 DIII 特异性抗体明显不同。ZK2B10 与 ZIKV 的结合对病毒与靶细胞的附着或 E 糖蛋白在酸性环境中的构象变化没有可检测到的影响,这表明 ZK2B10 的作用发生在融合中间产物形成和膜融合之间的步骤。这些结果提供了结构和机制方面的见解,说明 ZK2B10 如何介导对 ZIKV 感染的保护。

相似文献

1
Structural Basis for Neutralization and Protection by a Zika Virus-Specific Human Antibody.结构基础的中和与保护的寨卡病毒特异性的人类抗体。
Cell Rep. 2019 Mar 19;26(12):3360-3368.e5. doi: 10.1016/j.celrep.2019.02.062.
2
Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge.靶向 III 区侧脊的公共抗体谱系对寨卡病毒和登革热病毒的差异化中和作用机制。
J Exp Med. 2020 Feb 3;217(2). doi: 10.1084/jem.20191792.
3
Probing Zika Virus Neutralization Determinants with Glycoprotein Mutants Bearing Linear Epitope Insertions.用携带线性表位插入的糖蛋白突变体探测寨卡病毒中和决定簇。
J Virol. 2018 Aug 29;92(18). doi: 10.1128/JVI.00505-18. Print 2018 Sep 15.
4
Structural Basis of Zika Virus-Specific Antibody Protection.寨卡病毒特异性抗体保护的结构基础
Cell. 2016 Aug 11;166(4):1016-1027. doi: 10.1016/j.cell.2016.07.020. Epub 2016 Jul 27.
5
Development of a Potent and Protective Germline-Like Antibody Lineage Against Zika Virus in a Convalescent Human.从恢复期患者中开发出针对寨卡病毒的高效且具有保护作用的种系样抗体谱系。
Front Immunol. 2019 Oct 24;10:2424. doi: 10.3389/fimmu.2019.02424. eCollection 2019.
6
Zika Virus Envelope Protein and Antibody Complexes.寨卡病毒包膜蛋白与抗体复合物
Subcell Biochem. 2018;88:147-168. doi: 10.1007/978-981-10-8456-0_7.
7
Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein.人源单克隆抗体可强力中和寨卡病毒,并在包膜蛋白的侧脊选择逃逸突变。
J Virol. 2019 Jun 28;93(14). doi: 10.1128/JVI.00405-19. Print 2019 Jul 15.
8
Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.针对蜱传脑炎病毒和莱姆病病毒包膜蛋白的保护性/中和性单克隆抗体的分子基础。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.02132-18. Print 2019 Apr 15.
9
Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus.从感染寨卡病毒的患者中分离出的人中和抗体的分子决定因素。
Sci Transl Med. 2016 Dec 14;8(369):369ra179. doi: 10.1126/scitranslmed.aai8336.
10
A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.寨卡病毒包膜糖蛋白跨越结构域I和III的一个新型抗原位点是强效中和性人单克隆抗体的靶点。
J Virol. 2021 Apr 12;95(9). doi: 10.1128/JVI.02423-20.

引用本文的文献

1
From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity.从抗体到免疫:评估黄病毒保护和交叉反应的相关因素。
Vaccines (Basel). 2025 Apr 24;13(5):449. doi: 10.3390/vaccines13050449.
2
Peptides developed against receptor binding sites of the E glycoprotein neutralize tick-borne encephalitis virus.针对E糖蛋白受体结合位点开发的肽可中和蜱传脑炎病毒。
Sci Rep. 2025 Apr 3;15(1):11435. doi: 10.1038/s41598-025-95449-1.
3
Zafirlukast, as a viral inactivator, potently inhibits infection of several flaviviruses, including Zika virus, dengue virus, and yellow fever virus.
扎夫鲁司特作为一种病毒灭活剂,能强烈抑制几种黄病毒的感染,包括寨卡病毒、登革热病毒和黄热病病毒。
Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0016824. doi: 10.1128/aac.00168-24. Epub 2024 May 29.
4
Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina.rVSV疫苗针对恒河猴寨卡病毒感染的免疫原性和效力评估。
Front Virol. 2023;3. doi: 10.3389/fviro.2023.1108420. Epub 2023 Feb 28.
5
Plant-made vaccines against viral diseases in humans and farm animals.用于人类和家畜病毒性疾病的植物源疫苗。
Front Plant Sci. 2023 Mar 28;14:1170815. doi: 10.3389/fpls.2023.1170815. eCollection 2023.
6
Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement.来自 Zika 病毒感染细胞的细胞外囊泡展示出病毒 E 蛋白,该蛋白结合 ZIKV 中和抗体以防止感染增强。
EMBO J. 2023 Mar 15;42(6):e112096. doi: 10.15252/embj.2022112096. Epub 2023 Feb 3.
7
Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function.体细胞超突变和可变区框架突变有助于抗寨卡病毒单克隆抗体的结合和功能。
J Virol. 2022 Jun 8;96(11):e0007122. doi: 10.1128/jvi.00071-22. Epub 2022 May 16.
8
Plant-Derived Recombinant Vaccines against Zoonotic Viruses.针对人畜共患病毒的植物源重组疫苗。
Life (Basel). 2022 Jan 21;12(2):156. doi: 10.3390/life12020156.
9
How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika.抗体如何识别病原体病毒:HIV-1、SARS-CoV-2 和寨卡病毒抗体中和作用的结构相关性。
Viruses. 2021 Oct 19;13(10):2106. doi: 10.3390/v13102106.
10
Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy.强效类生殖系单克隆抗体:快速鉴定基于抗体的抗病毒疗法的有前景候选物。
Antib Ther. 2021 May 17;4(2):89-98. doi: 10.1093/abt/tbab008. eCollection 2021 Apr.